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Antenatal glucocorticoids have been used in pregnancies at risk for early 
preterm delivery since a consensus conference held by the National Institutes 
of Health in 1994. The multiple studies reviewed by this conference 
determined that injection of glucocorticoids reduces adverse neonatal 
outcomes when given to women who are likely to deliver before 34 weeks of 
gestation. In April 2016, the New England Journal of Medicine published a new 
study that investigated the use of corticosteroids in late preterm pregnancies 
(from 34 weeks 0 days to 36 weeks 6 days). This study demonstrated a clear 
improvement in neonatal respiratory outcomes. The current study was 
planned to examine whether an improvement has been made in neonatal 
morbidity at Jefferson Washington Township since the providers began 
administering antenatal corticosteroids to patients at risk of delivering in the 
late preterm period. 
A retrospective chart review was performed on patients and their infants born 
during 34 to 36.6 weeks gestational age from May 2014 to December 2018 in 
Jefferson Hospital at Washington Township. The primary objective was to assess 
the newborn’s need for respiratory support within 72 hours after birth, consisting 
of one or more of the following: the use of continuous positive airway pressure 
(CPAP) or high-flow nasal cannula for at least 2 consecutive hours, supplemental 
oxygen with a fraction of inspired oxygen of at least 0.30 for at least 4 continuous 
hours, extracorporeal membrane oxygenation (ECMO), or mechanical ventilation. 
Secondary objectives were the incidence of periventricular hemorrhage as seen on 
CT, ultrasound or MRI, neonatal death, length of NICU stay, neonatal 
hyperbilirubinemia, phototherapy, and neonatal hypoglycemia as defined as less 
than 45mg/dL.  A two group independent t-test was used for continuous variables 
and chi-square, Fisher’s exact tests for categorical, and logistic regression analyses 
were used to analyze differences between groups. 
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Contrary to the expected outcome, this study found unchanged rates of neonatal 
respiratory morbidity between infants whose mothers had received steroids and 
those who did not. Instead, the fully treated group of infants was found to have 
higher rates of jaundice and need for phototherapy with longer NICU stays. It is 
not completely clear what may have caused this correlation. One theory is the 
known effect of hyperglycemia in the mother from corticosteroids which may 
have caused a reflexive polycythemia in the fetus and therefore, red blood cell 
destruction and jaundice after birth. The rates of hyperbilirubinemia have been 
shown to be elevated in infants  given antenatal steroids in previous studies, 
although whether it could be modulated by strict maternal glycemic control has 
not yet been studied. The respiratory benefits demonstrated in previous studies 
may outweigh the morbidity of jaundice requiring phototherapy. Further studies 
are needed to possibly apply various protocols for maternal glycemic control 
after steroid administration and investigate whether there is a measurable 
benefit to the rates of neonatal jaundice.  
Chart 2. Confidence Intervals of Various Effects on Infants 
Results 
There were no significant differences between groups in the primary outcome. 
However, there was a significantly longer length of NICU stay (P= 0.0009) and 
neonatal hyperbilirubinemia (P=0.0063) in the treated group of late preterm 
infants. Similarly, infants whose mothers received a full course of steroids also 
had a significantly higher rate of phototherapy (P<0.001). Mothers with chronic 
hypertension were more likely to have a full course of treatment (P=0.0086) as 
were those with pre-eclampsia (P= 0.029) over those with other maternal 
complications including gestational hypertension. These results were not found 
to be altered by gestational age or time from steroid administration to delivery. 
Abstract 
Administration of steroids to mothers expected to deliver in the late preterm 
period has previously been found to decrease neonatal respiratory morbidity. 
In this retrospective chart review, there were no significant differences 
between groups in the primary outcome of required respiratory support for 
the neonate, incidence of periventricular hemorrhage or neonatal death. 
However, this study found that their rate of hyperbilirubinemia, need for 
phototherapy, and NICU stays were longer than their counterparts whose 
mothers did not receive steroids or who only received one dose. These 
findings may provide support for future protocols directed to improve 
neonatal morbidity secondary to jaundice.  
Chart 1. Comparison of Outcomes Between Treatment Groups 
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